Indrayani Biotech Limited has announced the appointment of Mr. C.S. Shanmuga Sundar as the new Company Secretary & Compliance Officer. This appointment, effective from September 9, 2026, follows the resignation of the previous officer. Mr. Sundar brings extensive experience in corporate secretarial functions, regulatory compliance, and corporate governance, having previously served with Peiner Smag Machinery.
Key Leadership Change at Indrayani Biotech
Indrayani Biotech Limited has officially announced a significant change in its senior management team. The Board of Directors, in a recent meeting, approved the appointment of Mr. C.S. Shanmuga Sundar as the new Company Secretary and Compliance Officer. This strategic appointment is effective from September 9, 2026.
Experienced Professional Joins the Team
Mr. C.S. Shanmuga Sundar (Membership No: A58375) steps into this role following the resignation of the previous incumbent. His professional background includes a qualification as an Associate Company Secretary (ACS) obtained on April 27, 2019. He possesses a rich and diverse professional experience, having worked across various industries. Throughout his career, Mr. Sundar has gained valuable exposure in critical areas such as corporate secretarial functions, statutory and regulatory compliance, corporate governance, and shareholder matters.
Previous Role and Expertise
Prior to joining Indrayani Biotech, Mr. Sundar served as the Company Secretary at Peiner Smag Machinery. In that capacity, he was responsible for overseeing the company’s secretarial, compliance, and corporate governance functions. His extensive experience is expected to bring significant knowledge and capability to Indrayani Biotech, particularly in managing corporate compliance and ensuring adherence to statutory and regulatory requirements.
Disclosure Details
According to the disclosures made, the appointment of Mr. C.S. Shanmuga Sundar is in his capacity as Company Secretary & Compliance Officer. His membership number is A58375. The appointment is consequent to the resignation of Ms. Ramya Ravi, effective June 3, 2026. Mr. Sundar has no disclosed relationships with the directors of the company.
Source: BSE
